PIA
MTEM

Piedmont Investment Advisors’s Molecular Templates, Inc. MTEM Stock Holding History

Piedmont Investment Advisors’s Portfolio MTEM Stock Details MTEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-10
Closed -$1K – 2483
2018
Q2 		$1K Buy
+10
New +$1.13K ﹤0.01% 2835

Other funds holding MTEM

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Piedmont Investment Advisors's MTEM Position: Q3 2018 in Review

Piedmont Investment Advisors sold out of Molecular Templates, Inc. (MTEM) in Q3 2018, closing a stake of 10 shares — an estimated $1K sold.

Piedmont Investment Advisors first reported a position in MTEM in Q2 2018 and held it in 1 quarter. The position peaked at $1K in Q2 2018. 62 funds tracked by Wall St. Rank hold MTEM as of Q3 2018.

  • Piedmont Investment Advisors reported no remaining Molecular Templates, Inc. position as of Q3 2018 after selling out during the quarter.
  • Piedmont Investment Advisors sold 10 Molecular Templates, Inc. shares in Q3 2018, an estimated $1K.
  • Piedmont Investment Advisors first reported a position in Molecular Templates, Inc. in Q2 2018 and held it in 1 quarter.
  • Piedmont Investment Advisors's Molecular Templates, Inc. position peaked at $1K in Q2 2018.
  • 62 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q3 2018.

Based on Piedmont Investment Advisors's 13F filing for Q3 2018, filed 8 Nov 2018.